ATAI
AtaiBeckley Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Neutral
+18/100
Last price
7.35
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
7.35
Day high
7.37
Day low
7.30
Volume
0
Market cap
$2.73B
P/E (TTM)
—
52W range
3.27 – 7.45
Trailing performance
Returnvs SPY
1W
+0.14%
-1.8%
1M
+1.66%
+0.2%
3M
—
-3.4%
6M
—
-14.9%
YTD
+1.80%
-12.1%
1Y
—
-15.7%
3Y
—
-81.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on ATAI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+559.23K
Net buying
Buy transactions
6
894.39K shares
Sell transactions
5
335.16K shares
Net transactions
+11
Buys less sells
Sell : buy shares
0.4 : 1
Mixed
Insider-held shares
8.10M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 7, 26 | HERSHBERG ROBERT M Director |
CONVERSION | 100.00K | $135.00K | Direct |
| Jul 7, 26 | HERSHBERG ROBERT M Director |
SELL | 100.00K | $496.00K | Direct |
| Jun 26, 26 | KOCHENDOERFER GRED Chief Operating Officer |
CONVERSION | 50.00K | $80.00K | Direct |
| Jun 26, 26 | KOCHENDOERFER GRED Chief Operating Officer |
SELL | 50.00K | $250.00K | Direct |
| Jun 25, 26 | CRAIG KEVIN JAMES M.D. Officer |
CONVERSION | 42.58K | $60.82K | Direct |
| Jun 25, 26 | CRAIG KEVIN JAMES M.D. Officer |
SELL | 42.58K | $192.03K | Direct |
| Apr 20, 26 | CRAIG KEVIN JAMES M.D. Officer |
CONVERSION | 42.58K | $69.07K | Direct |
| Apr 20, 26 | CRAIG KEVIN JAMES M.D. Officer |
SELL | 42.58K | $212.90K | Direct |
| Apr 8, 26 | ANGERMAYER CHRISTIAN Director and Beneficial Owner of more than 10% of a Class of Security |
CONVERSION | 559.23K | $897.30K | Direct |
| Mar 20, 26 | CRAIG KEVIN JAMES M.D. Officer |
CONVERSION | 100.00K | $125.61K | Direct |
| Mar 20, 26 | CRAIG KEVIN JAMES M.D. Officer |
SELL | 100.00K | $355.00K | Direct |
| Jan 2, 26 | FEILDING-MELLEN COSMO Director |
SELL | 39.59K | $154.38K | Direct |
| Nov 5, 25 | FEILDING-MELLEN COSMO Director |
— | 7.70M | — | Direct |
| Sep 30, 25 | APEIRON INVESTMENT GROUP LTD. Beneficial Owner of more than 10% of a Class of Security |
— | 2.37M | — | Indirect |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ANGERMAYER CHRISTIAN |
Director and Beneficial Owner of more than 10% of a Class of Security | 55.77M | Conversion of Exercise of derivative security |
APEIRON INVESTMENT GROUP LTD. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
CRAIG KEVIN JAMES M.D. |
Officer | 8.44K | Conversion of Exercise of derivative security |
FEILDING-MELLEN COSMO |
Director | 7.66M | Sale |
HERSHBERG ROBERT M |
Director | 100.00K | Conversion of Exercise of derivative security |
JOHNSON ANNE NAGENGAST |
Chief Financial Officer | 140.04K | Sale |
KIRPEKAR SAHIL |
Officer | 115.64K | Sale |
KOCHENDOERFER GRED |
Chief Operating Officer | 0 | Conversion of Exercise of derivative security |
RAO SRINIVAS |
Chief Executive Officer | 216.44K | Sale |
SHORT GLENN FRANK |
Officer | 42.33K | Sale |
Fundamentals
Market cap$2.73B
Enterprise value$2.50B
Revenue (TTM)$4.47M
Gross profit$-70.62M
EBITDA$-140.79M
Net income$-668.19M
EPS (TTM)$-2.79
Free cash flow$-74.67M
Total cash$225.81M
Total debt$4.29M
Book value / share$0.48
Shares outstanding370.86M
Float308.41M
Short % of float6.11%
Dividend yield—
Beta (5Y)1.55
Valuation & profitability ratios
Trailing P/E—
Forward P/E-15.31
PEG ratio—
Price / sales—
Price / book15.38
EV / revenue560.02
EV / EBITDA-17.79
Gross margin0.00%
Operating margin-2590.43%
Profit margin0.00%
Return on equity-417.21%
Return on assets-39.03%
Debt / equity2.43
Current ratio8.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $4.09M | $308.00K | $314.00K | $233.00K | +1,227.6% |
| Operating revenue | $4.09M | $308.00K | $314.00K | $233.00K | +1,227.6% |
| Research & development | $53.06M | $55.45M | $62.20M | $74.31M | -4.3% |
| Selling, general & admin | $65.09M | $47.54M | $63.58M | $70.35M | +36.9% |
| Total operating expense | $117.44M | $102.47M | $123.34M | $144.66M | +14.6% |
| Operating income | -$113.35M | -$102.17M | -$123.03M | -$144.43M | -10.9% |
| Net interest income | $316.00K | -$2.35M | -$809.00K | -$375.00K | +113.5% |
| Pre-tax income | -$659.85M | -$148.41M | -$39.29M | -$135.18M | -344.6% |
| Tax provision | $298.00K | -$356.00K | $1.02M | $6.23M | +183.7% |
| Net income | -$660.05M | -$149.27M | -$40.22M | -$152.38M | -342.2% |
| Net income to common | -$660.05M | -$149.27M | -$40.22M | -$152.38M | -342.2% |
| Basic EPS | -2.91 | -0.93 | -0.25 | -0.98 | -212.9% |
| Diluted EPS | -2.91 | -0.93 | -0.25 | -0.98 | -212.9% |
| EBIT | -$658.69M | -$145.28M | -$36.63M | -$134.26M | -353.4% |
| EBITDA | -$657.67M | -$144.81M | -$36.31M | -$134.09M | -354.2% |
| Basic shares | 226.53M | 160.16M | 158.83M | 155.72M | +41.4% |
| Diluted shares | 226.53M | 160.16M | 158.83M | 155.72M | +41.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $85.30M | $17.50M | $45.03M | $190.61M | — | +387.3% |
| Cash & short-term investments | $256.04M | $62.33M | $179.26M | $273.11M | — | +310.8% |
| Accounts receivable | $667.00K | $354.00K | — | — | — | +88.4% |
| Total current assets | $275.68M | $80.13M | $185.59M | $287.14M | — | +244.1% |
| Property, plant & equipment | $4.01M | $3.87M | $2.20M | $1.15M | — | +3.7% |
| Goodwill & intangibles | $3.18M | $3.58M | $1.77M | — | — | -11.0% |
| Total assets | $292.72M | $159.39M | $293.48M | $305.44M | — | +83.7% |
| Total current liabilities | $23.48M | $24.95M | $20.12M | $19.90M | — | -5.9% |
| Current debt | — | $9.36M | — | — | — | — |
| Long-term debt | — | $14.13M | $17.88M | $15.12M | $743.00K | — |
| Total debt | $2.07M | $24.71M | $19.14M | $15.34M | — | -91.6% |
| Total liabilities | $70.72M | $42.83M | $49.16M | $39.67M | — | +65.1% |
| Retained earnings | -$1.36B | -$700.21M | -$550.94M | -$510.19M | — | -94.3% |
| Shareholder equity | $221.87M | $116.30M | $242.96M | $260.74M | — | +90.8% |
| Working capital | $252.21M | $55.17M | $165.47M | $267.25M | — | +357.1% |
| Net tangible assets | $218.69M | $112.72M | $241.19M | $260.74M | — | +94.0% |
| Shares issued | 363.28M | 167.96M | 166.03M | 165.94M | — | +116.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$660.15M | -$150.05M | -$43.90M | -$157.42M | -340.0% |
| Depreciation & amortisation | $1.01M | $473.00K | $319.00K | $168.00K | +114.0% |
| Stock-based compensation | $14.21M | $25.49M | $32.98M | $42.38M | -44.2% |
| Change in working capital | -$6.47M | -$9.20M | $7.47M | -$3.33M | +29.6% |
| Operating cash flow | -$102.67M | -$82.44M | -$84.12M | -$104.47M | -24.5% |
| Capital expenditure | -$10.87M | -$95.00K | -$590.00K | -$1.02M | -11,340.0% |
| Investing cash flow | -$109.13M | $59.17M | -$53.30M | -$86.85M | -284.4% |
| Share buybacks | -$6.63M | $0 | — | — | — |
| Financing cash flow | $269.48M | $5.37M | -$8.36M | $20.79M | +4,914.5% |
| Free cash flow | -$113.54M | -$82.53M | -$84.71M | -$105.49M | -37.6% |
| End cash position | $85.30M | $27.50M | $45.03M | $190.61M | +210.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.70M | $954.00K | $1.07M | $749.00K | $719.00K | +78.6% |
| Operating revenue | $1.70M | $954.00K | $1.07M | $749.00K | $719.00K | +78.6% |
| Research & development | $28.07M | $17.41M | $15.96M | $14.68M | $11.09M | +61.2% |
| Selling, general & admin | $17.77M | $14.44M | $25.09M | $14.51M | $14.90M | +23.1% |
| Total operating expense | $43.43M | $31.11M | $40.42M | $29.16M | $25.96M | +39.6% |
| Operating income | -$41.72M | -$30.16M | -$39.35M | -$28.41M | -$25.25M | -38.3% |
| Net interest income | $79.00K | $78.00K | $542.00K | $504.00K | -$16.00K | +1.3% |
| Pre-tax income | -$32.48M | -$29.78M | -$544.92M | -$60.97M | -$27.65M | -9.1% |
| Tax provision | $64.00K | $20.00K | -$82.00K | $131.00K | $93.00K | +220.0% |
| Net income | -$32.52M | -$29.78M | -$544.81M | -$61.07M | -$27.73M | -9.2% |
| Net income to common | -$32.52M | -$29.78M | -$544.81M | -$61.07M | -$27.73M | -9.2% |
| Basic EPS | -0.09 | -0.08 | -1.73 | -0.28 | -0.14 | -12.5% |
| Diluted EPS | -0.09 | -0.08 | -1.73 | -0.28 | -0.14 | -12.5% |
| EBIT | -$32.48M | -$29.78M | -$544.92M | -$60.97M | -$27.39M | -9.1% |
| EBITDA | -$32.27M | -$29.61M | -$544.59M | -$60.73M | -$27.16M | -9.0% |
| Basic shares | 360.75M | 357.42M | 314.28M | 217.60M | 196.56M | +0.9% |
| Diluted shares | 360.75M | 357.42M | 314.28M | 217.60M | 196.56M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $168.81M | $43.10M | $85.30M | $30.40M | $61.94M | — | +291.6% |
| Cash & short-term investments | $225.81M | $230.77M | $256.04M | $114.61M | $95.94M | — | -2.1% |
| Accounts receivable | $647.00K | $864.00K | $667.00K | — | — | — | -25.1% |
| Total current assets | $244.75M | $250.07M | $275.68M | $130.67M | $102.68M | — | -2.1% |
| Property, plant & equipment | $3.65M | $3.86M | $4.01M | $5.67M | $5.70M | — | -5.5% |
| Goodwill & intangibles | $3.03M | $3.09M | $3.18M | $14.74M | $9.67M | — | -2.0% |
| Total assets | $264.79M | $264.88M | $292.72M | $239.82M | $189.20M | — | -0.0% |
| Total current liabilities | $28.53M | $24.96M | $23.48M | $16.54M | $25.55M | — | +14.3% |
| Current debt | — | — | — | — | $6.16M | $14.49M | — |
| Long-term debt | — | — | — | — | — | $9.30M | — |
| Total debt | $1.89M | $2.00M | $2.07M | $2.96M | $9.22M | — | -5.8% |
| Total liabilities | $88.36M | $66.10M | $70.72M | $79.91M | $45.28M | — | +33.7% |
| Retained earnings | -$1.42B | -$1.39B | -$1.36B | -$815.44M | -$754.37M | — | -2.3% |
| Shareholder equity | $176.37M | $198.68M | $221.87M | $159.75M | $143.74M | — | -11.2% |
| Working capital | $216.22M | $225.10M | $252.21M | $114.12M | $77.13M | — | -3.9% |
| Net tangible assets | $173.33M | $195.59M | $218.69M | $145.01M | $134.07M | — | -11.4% |
| Shares issued | 369.21M | 365.56M | 363.28M | 240.44M | 212.24M | — | +1.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$32.55M | -$29.80M | -$544.84M | -$61.10M | -$27.75M | — | -9.2% |
| Depreciation & amortisation | $215.00K | $167.00K | $336.00K | $233.00K | $227.00K | — | +28.7% |
| Stock-based compensation | $7.44M | $5.45M | $4.88M | $3.29M | $2.69M | — | +36.5% |
| Change in working capital | -$2.83M | $2.02M | -$11.29M | -$1.25M | $7.80M | — | -240.3% |
| Operating cash flow | -$35.27M | -$21.09M | -$47.48M | -$23.26M | -$14.09M | — | -67.2% |
| Capital expenditure | — | — | -$110.00K | -$5.36M | -$127.00K | -$5.27M | — |
| Investing cash flow | $158.59M | -$21.65M | -$40.34M | -$67.55M | $9.78M | — | +832.4% |
| Share buybacks | — | — | -$905.00K | -$3.56M | — | — | — |
| Financing cash flow | $2.64M | $821.00K | $142.38M | $59.74M | $7.76M | — | +221.1% |
| Free cash flow | -$35.27M | -$21.09M | -$47.59M | -$28.62M | -$14.22M | — | -67.2% |
| End cash position | $168.81M | $43.10M | $85.30M | $30.40M | $61.94M | — | +291.6% |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.11 | -0.09 | +19.5% |
| Mar 2026 | -0.11 | — | — |
| Dec 2025 | -0.11 | -1.73 | -1,441.6% |
| Sep 2025 | -0.12 | -0.28 | -125.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.12 | 5 | $218.18K | -70.9% |
| Next quarter | -0.13 | 5 | $218.18K | -79.5% |
| Current year | -0.42 | 5 | $3.06M | -25.2% |
| Next year | -0.48 | 7 | $600.00K | -80.4% |
Analyst targets & ownership
Mean target$8.12
High target$9.25
Low target$7.45
Implied upside10.43%
Analyst count6
ConsensusHOLD
Strong buy / Buy0 / 1
Hold12
Sell / Strong sell0 / 0
Held by insiders2.18%
Held by institutions52.30%
Institutions holding313
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
7.33
+0.25% from price
SMA 20
7.34
+0.12% from price
SMA 50
—
—
SMA 100
—
—
SMA 200
—
—
EMA 12
7.33
+0.21% from price
EMA 26
7.30
+0.64% from price
EMA 50
—
—
RSI (14)
54.0
Neutral
MACD (12,26,9)
0.03
Hist -0.01
ATR (14)
0.08
1.04% of price
Realised vol 30D
9.3%
Annualised
Bollinger upper
7.44
20, 2σ
Bollinger lower
7.24
20, 2σ
50 / 200 cross
—
—
Trend bias
—
—
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
—
—
Correlation to SPY
—
—
Realised vol 30D
9.3%
Annualised
Market vol 1Y
—
SPY, annualised
Max drawdown 1Y
-2.2%
Peak to trough
Max drawdown 5Y
-2.2%
Peak to trough
ATR 14
0.08
1.04% of price
Beta (reported)
1.55
5Y monthly, from filing
Short interest
Shares short
19.20M
Prior 19.86M
Change vs prior
-3.3%
Shorts covering
% of float
6.11%
Normal
% of shares out
5.18%
Against total outstanding
Days to cover
2.8
Liquid
Float
308.41M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 12, 26 | Deutsche Bank | DOWNGRADE | Buy | Hold |
| Jul 20, 26 | HC Wainwright & Co. | DOWNGRADE | Buy | Neutral |
| Jul 17, 26 | Guggenheim | DOWNGRADE | Buy | Neutral |
| Jul 17, 26 | Jones Trading | DOWNGRADE | Buy | Hold |
| Jul 17, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Jul 16, 26 | Maxim Group | DOWNGRADE | Buy | Hold |
| Jul 16, 26 | Canaccord Genuity | DOWNGRADE | Buy | Hold |
| Jul 16, 26 | Needham | DOWNGRADE | Buy | Hold |
| Jul 7, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| Jul 6, 26 | Jefferies | MAINTAINED | Buy | Buy |
| Jun 8, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 20, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
SEC filings
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM · 2026-09-11
Corporate Changes & Voting Matters
8-K · 2026-09-08
Corporate Changes & Voting Matters
8-K · 2026-08-31
Periodic Financial Reports
10-Q · 2026-08-11
Proxy Statements
DEFM14A · 2026-08-10
Proxy Statements
PREM14A · 2026-07-30
Proxy Statements
DEFA14A · 2026-07-16
Corporate Changes & Voting Matters
8-K · 2026-06-08
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.